ADMA Biologics, Inc. (ADMA)
16.10
-0.22
(-1.35%)
USD |
NASDAQ |
Feb 20, 16:00
16.10
0.00 (0.00%)
After-Hours: 20:00
ADMA Biologics SG&A Expense (Quarterly) : 23.05M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 1.024M |
| Arcutis Biotherapeutics, Inc. | 62.40M |
| CorMedix, Inc. | 36.64M |
| AtriCure, Inc. | 78.34M |
| Ligand Pharmaceuticals, Inc. | 28.45M |